Due to routine maintenance, access to the Library Open Repository will be interrupted on the morning of Friday 12th February.
We apologise for any inconvenience.

Library Open Repository

Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases

Downloads

Downloads per month over past year

Ding, C (2008) Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases. Expert Opinion on Biological Therapy, 8 (11). pp. 1805-1814.

[img] PDF
Ding_Expert_Opi...pdf | Request a copy
Full text restricted
Available under University of Tasmania Standard License.

Abstract

B lymphocyte stimulator (BLyS) is a factor determining the survival of B cells, and elevated levels in serum or locally have been observed in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients. Belimumab (LymphoStat-B), a human monoclonal antibody that inhibits BlyS, was developed for the treatment of these diseases. OBJECTIVE: To summarize preclinical development, efficacy and safety of belimumab in treatment of RA and SLE. METHODS: Articles found in a PubMed search and data presented in abstract form at international conferences up to August 2008 are described. RESULTS/CONCLUSIONS: Belimumab was well tolerated in treatment of RA over 24 weeks and SLE over 3 years. It significantly decreased rheumatoid factor (RF) levels, and modestly reduced symptoms of RA, especially in some subgroups such as patients with high disease activity, positive RF and no anti-TNF treatment experience. It also significantly reduced symptoms of SLE, and decreased anti-double-stranded DNA autoantibodies among patients with positive baseline anti-double-stranded DNA or antinuclear antibodies during a long-period treatment. These results suggest that careful patient selection is necessary to achieve optimal outcomes.

Item Type: Article
Keywords: BLyS Belimumab autoimmune
Journal or Publication Title: Expert Opinion on Biological Therapy
Page Range: pp. 1805-1814
Identification Number - DOI: 10.1517/14712598.8.11.1805
Additional Information: Copyright © 2009 Informa plc
Date Deposited: 02 Mar 2009 23:20
Last Modified: 18 Nov 2014 03:56
Item Statistics: View statistics for this item

Repository Staff Only (login required)

Item Control Page Item Control Page